Lab Information
Peter Lakatos (MD)
InvestigatorClinical Research Unit
Department of Medicine (McGill)
Research Profile
Keywords
Inflammatory bowel diseases (IBD) • gastroenterology • colitis • Crohn’s diseaseTeam Members
| Name | Position |
|---|
Latest Publications
- Lontai, L., Elek, L. P., Balogh, F., Angyal, D., Pajkossy, P., Gonczi, L., Lakatos, P. L. & Iliás, Á. (2024). Burden of Mental Health among Patients with Inflammatory Bowel Disease-A Cross-Sectional Study from a Tertiary IBD Center in Hungary. Journal of clinical medicine, vol. 13.
- Bacsur, P., Wetwittayakhlang, P., Resál, T., Földi, E., Vasas, B., Farkas, B., Rutka, M., Bessissow, T., Afif, W., Bálint, A., Fábián, A., Bor, R., Szepes, Z., Farkas, K., Lakatos, P. L. & Molnár, T. (2024). Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system. Therapeutic advances in gastroenterology, vol. 17, p. 17562848241239606.
- Wetwittayakhlang, P. & Lakatos, P. L. (2024). Unravelling the Smoke Trail: Maternal Smoking, Childhood Exposure, and their Impact on Inflammatory Bowel Diseases. Journal of Crohn's & colitis.
- Gonczi, L., Lakatos, L., Ilias, A. & Lakatos, P. L. (2024). Editorial: The prevalence and outcomes of perianal Crohn's disease across the treatment eras-Authors' reply. Alimentary pharmacology & therapeutics, vol. 59, p. 715-716.
- Wetwittayakhlang, P. & Lakatos, P. L. (2024). Current Evidence for Combined Targeted Therapy for the Treatment of Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology, vol. 7, p. 22-29.
- Wetwittayakhlang, P., Bessissow, T. & Lakatos, P. L. (2024). Novel and emerging drugs for the treatment of Crohn's disease: a review of phase II and III trials. Expert opinion on emerging drugs, vol. 29, p. 19-34.
- Gonczi, L., Lakatos, L., Golovics, P. A., Angyal, D., Balogh, F., Ilias, A., Pandur, T., David, G., Erdelyi, Z., Szita, I. & Lakatos, P. L. (2024). Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades - Results from a population-based study over four decades. Alimentary pharmacology & therapeutics, vol. 59, p. 656-665.
- Al-Jabri, R., Wetwittayakhlang, P. & Lakatos, P. L. (2023). Monitoring of Inflammatory Bowel Disease in Pregnancy: A Review of the Different Modalities. Journal of clinical medicine, vol. 12.
- Resál, T., Bacsur, P., Keresztes, C., Bálint, A., Bor, R., Fábián, A., Farkas, B., Katsanos, K., Michalopoylos, G., Ribaldone, D. G., Attauabi, M., Zhao, M., Barak, H. A., Yanai, H., Bezzio, C., Rispo, A., Castiglione, F., Bar-Gil Shitrit, A., Pugliese, D., Armuzzi, A., Savarino, E. V., Kolar, M., Lukáš, M., Chashkova, E., Filip, R., Rozieres, A., Nancey, S., Krznarić, Ž., Schäfer, E., , Sarlós, P., Franko, M., Drobne, D., Knyazev, O. V., Kagramanova, A. V., Limdi, J., Wetwittayakhlang, P., Lakatos, P. L., Maharshak, N., Bannon, L., Nyári, T., Szepes, Z., Farkas, K., TFB Study Group & Molnár, T. (2023). Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study. Inflammatory bowel diseases.
- Gonczi, L., Lakatos, L., Golovics, P. A., Ilias, A., Pandur, T., David, G., Erdelyi, Z., Szita, I., Al Khoury, A. & Lakatos, P. L. (2023). Declining trends of reoperations and disease behavior progression in Crohn's disease over different therapeutic eras - a prospective population-based study from western Hungary between 1977-2020, data from the Veszprem cohort. Journal of Crohn's & colitis, vol. 17, p. 1980-1987.
See also
